| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |